Table 2.
The level of isoprostanes (pg/ml) in patients before (T0) and after 3 months of treatment with diosmin (T3m).
| 8-iso-15(R)-PGF2α | 8-iso-PGF2α | 11β-PGF2α | 15(R)-PGF2α | Total | |
|---|---|---|---|---|---|
| T0 | 3.09 | 6.61 | 10.54 | 19.41 | 39.65 |
| T3m | 4.28 | 5.91 | 1.29 | 12.50 | 23.97 |
The level of isoprostanes (pg/ml) in patients before (T0) and after 3 months of treatment with diosmin (T3m).
| 8-iso-15(R)-PGF2α | 8-iso-PGF2α | 11β-PGF2α | 15(R)-PGF2α | Total | |
|---|---|---|---|---|---|
| T0 | 3.09 | 6.61 | 10.54 | 19.41 | 39.65 |
| T3m | 4.28 | 5.91 | 1.29 | 12.50 | 23.97 |